Elizabeth Glaser Pediatric Aids Foundation

Researchers are studying whether an enhanced package of care helps people with advanced HIV in Malawi stay in treatment and keep the virus suppressed. The package adds CD4 and TB-LAM tests and starts patients on TB preventive therapy, delivered through a hub-and-spoke system of c…

Researchers are studying whether adding rapid antigen testing for SARS-CoV-2 to HIV, maternal and child health, and tuberculosis clinics in Cameroon and Kenya increases the number of people tested and diagnosed with COVID-19. The study compares clinic activity before and after th…

Researchers follow more than 1,200 HIV-positive pregnant and postpartum women in Kigali, Rwanda, who receive standard HIV care through prevention of mother-to-child transmission programs. The study tracks whether their babies remain HIV-free through 18 to 24 months of age while m…

This trial tests whether mobile phone communication helps HIV-positive pregnant women in Kenya complete the steps that prevent passing HIV to their babies. Twenty-six health facilities are assigned to either standard care or standard care plus phone-based support for mothers, mal…

Researchers are tracking birth outcomes for infants born in Eswatini to mothers who took dolutegravir or other HIV drugs around the time of conception. The study compares rates of neural tube defects and other birth defects among babies born to HIV-positive women on dolutegravir,…

Researchers are collecting health records from young people with HIV in ten African countries who have taken the drugs darunavir, etravirine, or both. The study follows their demographics, clinical and laboratory profiles, and HIV drug resistance over time. The goal is to underst…